mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.04 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |